Accurate diagnosis and monitoring.
Accurate diagnosis and monitoring.
Undiagnosed, celiac disease can lead to long-term complications, and as many as 1 in 100 people worldwide are affected by the disease. That’s why we offer clinicians a comprehensive line of test options with QUANTA Lite®, QUANTA Flash®, and NOVA Lite® assays. Our tests include the most clinically relevant biomarkers to ensure accurate diagnosis and follow up testing, which may help patients avoid the long-term complications.
- Patient care and comfort.With accurate testing, patients can be diagnosed faster and potentially avoid invasive procedures.
- Confident lab technicians.With high-quality tests that correlate with clinical disease parameters, labs can feel confident that they are reporting the most accurate results to clinicians.
- Helping clinicians every step of the way.Using Deamidated Gliadin Peptide (DGP) and human tissue Transglutaminase (htTG) in combination can help stratify patients for biopsy or gluten free diet.
Reagents
QUANTA Lite® (ELISA)
QUANTA Flash® (CIA)
NOVA Lite® (IFA)
Related Systems
BIO-FLASH®
Autoimmune chemiluminescent (CIA) analyzer eliminates batching and provides precise quantification.
NOVA View®
Digital immunofluorescence assay (IFA) system with single well titer to increase the efficiency of your workflow.
QUANTA-Lyser® 3000
QUANTA-Lyser 3000 is a high throughput EIA/IFA that give you the ability to complete your workload faster with less hands-on time.
